Cancer and neoplasms
Adjuvant Radiotherapy in Patients with High-risk Primary Cutaneous Squamous Cell Carcinoma AFTER surgery (SCC-AFTER): An Open Label, Multicentre, Two-arm Phase III Randomised trial.
Research question
In patients who have a high-risk primary cutaneous squamous cell carcinoma (HR-cSCC)
surgically excised with clear margins,is adjuvant radiotherapy plus close clinical follow-up superior
in reducing the risk of loco-regional recurrence compared with close clinical follow-up alone,and if
so,is it cost-effective?
Background
cSCC is the second most common skin cancer in the UK,with annual incidence exceeding
52,000,increasing by 6% p.a (1,2). Treatment,usually surgery,is curative in 95% (3,4).
However,5% of patients develop loco-regional recurrence (LRR) which causes 75% of cSCCspecific
mortality,substantial morbidity and reduced quality of life (QoL) ...
GO TO STUDY